These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1732426)

  • 21. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual improvement despite radiologically stable disease after treatment with carboplatin in children with progressive low-grade optic/thalamic gliomas.
    Mitchell AE; Elder JE; Mackey DA; Waters KD; Ashley DM
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):572-7. PubMed ID: 11902299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II trial of iproplatin (CHIP) in previously treated advanced breast cancer.
    Meisner DJ; Ginsberg S; Ditch A; Louie A; Newman N; Comis R; Poiesz B
    Am J Clin Oncol; 1989 Apr; 12(2):129-31. PubMed ID: 2705402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I study of weekly-administered iproplatin [cis-dichloro-trans-dihydroxy-bis-isopropylamine platin (chip, JM9)].
    Chawla SP; Yap BS; Tenney DM; Bodey GP; Benjamin RS
    Invest New Drugs; 1988 Dec; 6(4):311-7. PubMed ID: 3229943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial.
    Gaynon PS; Ettinger LJ; Baum ES; Siegel SE; Krailo MD; Hammond GD
    Cancer; 1990 Dec; 66(12):2465-9. PubMed ID: 2249186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II evaluation of topotecan for pediatric central nervous system tumors.
    Blaney SM; Phillips PC; Packer RJ; Heideman RL; Berg SL; Adamson PC; Allen JC; Sallan SE; Jakacki RI; Lange BJ; Reaman GH; Horowitz ME; Poplack DG; Balis FM
    Cancer; 1996 Aug; 78(3):527-31. PubMed ID: 8697400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study.
    Robins HI; Chang SM; Prados MD; Yung WK; Hess K; Schiff D; Greenberg H; Fink K; Nicolas K; Kuhn JG; Cloughesy T; Junck L; Mehta M
    Neuro Oncol; 2002 Apr; 4(2):109-14. PubMed ID: 11916502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas: a phase II study.
    Aquino VM; Fort DW; Kamen BA
    J Neurooncol; 1999 Feb; 41(3):255-9. PubMed ID: 10359145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of adults with progressive oligodendroglioma with carboplatin (CBDCA): preliminary results. Writing Committee for The Brain Tumor Center at Duke.
    Friedman HS; Lovell S; Rasheed K; Friedman AH
    Med Pediatr Oncol; 1998 Jul; 31(1):16-8. PubMed ID: 9607424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin.
    Hecquet B; Caty A; Fournier C; Lefebvre JL; Adenis L
    Bull Cancer; 1987; 74(4):433-6. PubMed ID: 3311237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I--preliminary phase II trial of iproplatin, a cisplatin analogue.
    Paolozzi FP; Gaver R; Poiesz BJ; Louie A; DiFino S; Comis RL; Newman N; Ginsberg S
    Invest New Drugs; 1988 Sep; 6(3):199-206. PubMed ID: 3192385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity.
    Goren MP; Forastiere AA; Wright RK; Horowitz ME; Dodge RK; Kamen BA; Viar MJ; Pratt CB
    Cancer Chemother Pharmacol; 1987; 19(1):57-60. PubMed ID: 2880677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II study of intravenous carboplatin for the treatment of recurrent gliomas.
    Warnick RE; Prados MD; Mack EE; Chandler KL; Doz F; Rabbitt JE; Malec MK
    J Neurooncol; 1994; 19(1):69-74. PubMed ID: 7815106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antitumor effect of carboplatin and iproplatin on human urinary bladder and prostatic cancers grown in nude mice].
    Hasegawa J; Kawamura N; Yamada S; Tsuboi N; Akimoto M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3279-83. PubMed ID: 3318705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinoma.
    Murphy D; Lind MJ; Prendiville J; Renninson J; Smith DR; Thompson G; Ranson M; Crowther D
    Eur J Cancer; 1992; 28A(4-5):870-2. PubMed ID: 1524912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
    Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
    J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I study of iproplatin in pediatric patients: a Pediatric Oncology Group Study.
    Pratt CB; Kamen BA; Winick N; Sartain P; Champion JE; Ragab AH; Goren MP
    Cancer Treat Rep; 1987 Jan; 71(1):87-8. PubMed ID: 3791272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical development of iproplatin (CHIP).
    Creaven PJ; Pendyala L; Madajewicz S
    Drugs Exp Clin Res; 1986; 12(1-3):287-92. PubMed ID: 3732051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.